It might sound strange at first that a diabetes and weight loss drug has the potential to treat addiction disorders, but observations from researchers have led to emerging data, anecdotal reports, and pharmacoepidemiologic findings that suggest GLP-1 drugs could be effective for addiction by reducing drug use and craving through the modulation of reward pathways, stress responses, and cognitive functions
(2019) Randomized controlled trial of N-acetylcysteine versus l-carnitine among women with clomiphene-citrate-resistant polycystic ovary syndrome
PlexusDx makes this advanced therapy accessible across all 50 states with transparent pricing and no insurance requirement
If you're looking for a more reasonably priced investment, you may want to consider Amgen (AMGN +1.12%)
The former CEO of Vital Proteins transitioned to Supergut, a company making GLP-1 booster products
Lipo-C , a lipotropic injection containing methionine, inositol, choline, and often combined with L-carnitine, supports fat metabolism through nutrient cofactors rather than peptide signaling
